Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2018 December;60(4) > Panminerva Medica 2018 December;60(4):238-40

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 December;60(4):238-40

DOI: 10.23736/S0031-0808.18.03428-6

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Novel drug delivery approaches in treating pulmonary fibrosis

Kamal DUA 1, 2, 3 , Rajendra AWASTHI 4, Jyotsana R. MADAN 5, Dinesh K. CHELLAPPAN 6, Buchi N. NALLURI 7, Gaurav GUPTA 8, Mary BEBAWY 1, Philip M. HANSBRO 1, 2, 3

1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 2 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 3 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, Australia; 4 NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; 5 Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India; 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia: 7 Department of Pharmaceutics, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India; 8 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, India


PDF


inizio pagina